Parallel Advisors, LLC Corcept Therapeutics Inc Transaction History

Parallel Advisors, LLC

$4.87 Billion
Q2 2025

A detailed history of Parallel Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 3,871,123 shares of CORT stock, worth $291 Million. This represents 5.83% of its overall portfolio holdings.

Number of Shares

3,871,123

Previous 3,972,416 2.55%

Holding current value

$291 Million

Previous $217 Million 30.93%

% of portfolio

5.83%

Previous 5.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 07, 2025	SELL	$62.24 - $91.93 $6.3 Million - $9.31 Million	-101,293 Reduced 2.55%	3,871,123 $284 Million
Q1 2025 Apr 07, 2025	BUY	$49.85 - $114.22 $7.12 Million - $16.3 Million	142,784 Added 3.73%	3,972,416 $217 Million
Q4 2024 Feb 10, 2025	BUY	$44.66 - $60.85 $710,451 - $968,001	15,908 Added 0.42%	3,829,632 $193 Million
Q3 2024 Nov 13, 2024	SELL	$29.51 - $46.26 $60,082 - $94,185	-2,036 Reduced 0.05%	3,813,724 $176 Million
Q2 2024 Aug 08, 2024	BUY	$22.21 - $34.48 $1,843 - $2,861	83 Added 0.0%	3,815,760 $124 Million
Q1 2024 May 06, 2024	BUY	$21.1 - $27.46 $1 Million - $1.3 Million	47,432 Added 1.26%	3,815,677 $96.1 Million
Q4 2023 Feb 09, 2024	BUY	$24.82 - $32.88 $1.11 Million - $1.47 Million	44,762 Added 1.2%	3,768,245 $122 Million
Q3 2023 May 20, 2024	SELL	$21.97 - $33.8 $67,711 - $104,171	-3,082 Reduced 0.08%	3,723,483 $101 Million
Q3 2023 Nov 13, 2023	SELL	$21.97 - $33.8 $67,711 - $104,171	-3,082 Reduced 0.08%	3,723,483 $101 Million
Q2 2023 May 20, 2024	BUY	$21.44 - $25.15 $42,708 - $50,098	1,992 Added 0.05%	3,726,565 $82.9 Million
Q2 2023 Aug 04, 2023	BUY	$21.44 - $25.15 $42,708 - $50,098	1,992 Added 0.05%	3,726,565 $82.9 Million
Q1 2023 May 20, 2024	SELL	$19.2 - $24.47 $1.75 Million - $2.23 Million	-91,104 Reduced 2.39%	3,724,573 $80.7 Million
Q1 2023 Apr 25, 2023	SELL	$19.2 - $24.47 $1,747 - $2,226	-91 Reduced -0.0%	3,724,573 $80.7 Million
Q4 2022 Feb 03, 2023	SELL	$19.95 - $29.96 $893,580 - $1.34 Million	-44,791 Reduced 1.19%	3,724,664 $75.6 Million
Q3 2022 Nov 10, 2022	BUY	$24.7 - $29.12 $26 Million - $30.6 Million	1,051,127 Added 38.67%	3,769,455 $96.6 Million
Q2 2022 Aug 01, 2022	BUY	$17.33 - $25.3 $13.4 Million - $19.6 Million	774,009 Added 39.81%	2,718,328 $64.6 Million
Q1 2022 Apr 28, 2022	BUY	$16.53 - $25.21 $2.33 Million - $3.55 Million	140,937 Added 7.82%	1,944,319 $47 Million
Q4 2021 Jan 20, 2022	BUY	$17.1 - $23.34 $1.31 Million - $1.78 Million	76,474 Added 4.43%	1,803,382 $35.7 Million
Q3 2021 Nov 02, 2021	BUY	$19.68 - $22.53 $1.03 Million - $1.18 Million	52,551 Added 3.14%	1,726,908 $34 Million
Q2 2021 Aug 06, 2021	BUY	$19.97 - $24.43 $2.2 Million - $2.7 Million	110,383 Added 7.06%	1,674,357 $36.8 Million
Q1 2021 Apr 23, 2021	BUY	$23.49 - $30.56 $360,759 - $469,340	15,358 Added 0.99%	1,563,974 $37.2 Million
Q4 2020 Feb 02, 2021	BUY	$16.78 - $27.3 $4.26 Million - $6.93 Million	253,712 Added 19.59%	1,548,616 $40.5 Million
Q3 2020 Oct 27, 2020	SELL	$12.46 - $19.98 $1.36 Million - $2.19 Million	-109,541 Reduced 7.8%	1,294,904 $22.5 Million
Q2 2020 Jul 16, 2020	SELL	$11.0 - $18.26 $15,950 - $26,477	-1,450 Reduced 0.1%	1,404,445 $23.6 Million
Q4 2019 Jan 30, 2020	BUY	$12.06 - $16.96 $1.54 Million - $2.17 Million	128,044 Added 10.02%	1,405,895 $17 Million
Q3 2019 Nov 01, 2019	BUY	$10.41 - $14.66 $13.3 Million - $18.7 Million	1,275,251 Added 49048.12%	1,277,851 $18.1 Million
Q2 2019 Aug 05, 2019	BUY	$9.78 - $12.76 $25,428 - $33,176	2,600 New	2,600 $29,000

Others Institutions Holding CORT

# of Institutions

467

Shares Held

82.8M

Call Options Held

489K

Put Options Held

1.02M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $8.05B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Corcept Therapeutics Inc Transaction History